Skip to content

Clinical trials

Observational Myasthenia Gravis trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myasthenia Gravis Phase: Observational Country / region: United States Clear all

36 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20101
20133
20151
20162
20171
20181
20192
20202
20213
20235
20246
20253
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting16
Completed12
Enrolling by invitation2
Not yet recruiting2
Unknown status2
Suspended1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Yale University3
argenx3
Alexion Pharmaceuticals, Inc.2
BioSensics2
Duke University2
George Washington University2
ProgenaBiome2
ZS Associates2
Ad scientiam1
Autoimmune Neurology Alliance1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myasthenia Gravis36
Multiple Sclerosis7
Autoimmune Diseases5
Alzheimer Disease4
Amyotrophic Lateral Sclerosis4
Autoimmune Diseases of the Nervous System4
Celiac Disease4
Colitis, Ulcerative4
Crohn Disease4
Parkinson Disease4

Trials

Showing 1 to 25 of 36. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.